Benzinga | Sep 20, 2021 04:31AM EDT

Keybanc Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $710

Keybanc analyst Paul Knight maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $555 to $710.